CDKN1B and neoplasm: In conclusion, this study demonstrated that HK2 could activate ERK1/2 through the Raf/MEK signaling pathway, further promoting cell proliferation and tumor formation by inducing cyclin A1, c-myc and reducing p27 in cervical cancer cells.